Lichen Sclerosus et AtrophicusInduced by Carbamazepine: A Case Report

We report a case of Lichen Sclerosusin a 73-year-old man who had been treated for epilepsy with carbamazepine. Lichen sclerosus et atrophicus(LSA), also called lichen sclerosus (LS), is a chronic inflammatory cutaneous condition characterized by white plaques with epidermal atrophy and scarring. To date no cases of LSA has been linked to carbamazepine, although in a few cases lichenoid eruptions but without sclero-atrophy have been described after exposure to this drug. Therefore, to our knowledge, this is the first report of a Lichen sclerosus et atrophicusinduced by carbamazepine